Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. (Q34708878)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. |
scientific article |
Statements
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells (English)
Deanna Teoh
Tina A Ayeni
Jennifer M Rubatt
David J Adams
Lisa Grace
Mark D Starr
William T Barry
Angeles Alvarez Secord
3 January 2011